Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Quick Links Investor Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases January 23, 2024 Incyte to Report Fourth Quarter and Year-End 2023 Financial Results January 8, 2024 Incyte Highlights Growth Opportunities and Provides Business Updates at the 42nd Annual J.P. Morgan Healthcare Conference December 12, 2023 Incyte to Present at Upcoming Investor Conferences All press releases Latest Events Feb 13 2024 Feb 13 2024 Q4 2023 Incyte Corporation Earnings Conference Call Click here for Webcast Jan 8 2024 Jan 8 2024 J. P. Morgan Healthcare Conference Click here for Webcast All events
